News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Jun 16, 2020 Corporate and finance Novavax Appoints Biotechnology Veteran David Mott to Board of Directors Download Jun 15, 2020 Corporate and finance Novavax to Raise $200 Million from Private Placement with RA Capital Download Jun 8, 2020 COVID-19 Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital Download Jun 4, 2020 COVID-19 Novavax Awarded Department of Defense Contract for COVID-19 Vaccine Download Jun 3, 2020 Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine Download May 27, 2020 Corporate and finance Novavax Expands Large-Scale Global Manufacturing Capacity Download May 25, 2020 COVID-19 Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine Download May 11, 2020 COVID-19 Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series Download May 11, 2020 COVID-19 Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing Download May 11, 2020 Corporate and finance Novavax Reports First Quarter 2020 Financial Results Download May 6, 2020 Corporate and finance Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 11, 2020 Download Apr 8, 2020 COVID-19 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May Download Mar 24, 2020 Seasonal influenza Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial Download Mar 11, 2020 Partnerships Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate Download Mar 11, 2020 Corporate and finance Novavax Reports Fourth Quarter and Full Year 2019 Financial Results Download Mar 10, 2020 COVID-19 Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development Download Mar 5, 2020 Corporate and finance Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results on March 11, 2020 Download Feb 26, 2020 COVID-19 Novavax Advances Development of Novel COVID-19 Vaccine Download Feb 25, 2020 Seasonal influenza Novavax’ Preclinical NanoFlu Data Published in Vaccines; Details Structural Basis for Broadly Neutralizing Immunity Download Jan 15, 2020 Seasonal influenza Novavax Granted Fast Track Designation for NanoFlu in Older Adults Download Jan 9, 2020 Corporate and finance Novavax to Present at the 38th Annual J.P. Morgan Healthcare Conference Download Nov 7, 2019 Corporate and finance Novavax Reports Third Quarter 2019 Financial Results Download Oct 31, 2019 Corporate and finance Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2019 Download Oct 15, 2019 Seasonal influenza Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults Download Sep 19, 2019 Corporate and finance Novavax to Present at the Ladenburg Thalmann 2019 Healthcare Conference Download Sep 6, 2019 Corporate and finance Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference Download Aug 12, 2019 RSV New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting Download Aug 8, 2019 RSV Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting Download Aug 7, 2019 Corporate and finance Novavax Reports Second Quarter 2019 Financial Results Download Aug 5, 2019 Seasonal influenza Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu Download Aug 1, 2019 Corporate and finance Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019 Download Jul 31, 2019 Partnerships Novavax and Catalent Announce Closing of Strategic Partnership Download Jun 27, 2019 Partnerships Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities Download Jun 27, 2019 Seasonal influenza Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™ Download Jun 10, 2019 RSV Novavax Provides Updates on the Global Pathways to Licensure for ResVax™ Download Jun 4, 2019 Seasonal influenza Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention Download May 10, 2019 Corporate and finance Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023 Download May 8, 2019 Corporate and finance Novavax Announces Reverse Stock Split of Common Stock Download May 2, 2019 Corporate and finance Novavax Reports First Quarter 2019 Financial Results Download May 1, 2019 RSV Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization Program at 37th Annual Meeting of the European Society for Pediatric Infectious Diseases Download Apr 25, 2019 Corporate and finance Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 2019 Download Apr 9, 2019 RSV Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress Download Mar 18, 2019 Corporate and finance Novavax Reports Fourth Quarter and Year-End 2018 Financial Results Download Mar 11, 2019 Corporate and finance Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 18, 2019 Download Feb 28, 2019 RSV Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization Download Jan 3, 2019 Seasonal influenza Novavax Announces Positive Phase 2 NanoFlu Results in Older Adults Download Jan 2, 2019 Corporate and finance Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference Download Dec 4, 2018 Corporate and finance Novavax Announces Leadership Promotions Download Nov 12, 2018 Corporate and finance Novavax Expands Leadership with Several Key Management Promotions Download Nov 7, 2018 Corporate and finance Novavax Reports Third Quarter 2018 Financial Results Download Show 5102550100 per page«12345678»